Literature DB >> 11274992

Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats.

E A Matthews1, A H Dickenson.   

Abstract

Plasticity in transmission and modulatory systems are implicated in mechanisms of neuropathic pain. Studies demonstrate the importance of high voltage-activated Ca(2+) channels in pain transmission, but the role of low voltage-activated, T-type Ca(2+) channels in nociception has not been investigated. The Kim and Chung rodent model of neuropathy [Pain 50 (1992) 355] was used to induce mechanical and cold allodynia in the ipsilateral hindpaw. In vivo electrophysiological techniques were used to record the response of dorsal horn neurones to innocuous and noxious electrical and natural (mechanical and thermal) stimuli after spinal nerve ligation. Spinal ethosuximide (5-1055 microg) exerted dose-related inhibitions of both the electrically and low- and high-intensity mechanical and thermal evoked neuronal responses and its profile remained unaltered after neuropathy. Measures of spinal cord hyperexcitability were most susceptible to ethosuximide. This study, for the first time, indicates a possible role for low voltage-activated Ca(2+) channels in sensory transmission.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274992     DOI: 10.1016/s0014-2999(01)00812-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  32 in total

Review 1.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 2.  Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors:  Anne Marie R Yunker
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 3.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 4.  Calcium channel functions in pain processing.

Authors:  John Park; Z David Luo
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

5.  Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.

Authors:  Emmanuel Bourinet; Abdelkrim Alloui; Arnaud Monteil; Christian Barrère; Brigitte Couette; Olivier Poirot; Anne Pages; John McRory; Terrance P Snutch; Alain Eschalier; Joël Nargeot
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

Review 6.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

7.  Characterisation of rebound depolarisation in mice deep dorsal horn neurons in vitro.

Authors:  Ivan Rivera-Arconada; Jose A Lopez-Garcia
Journal:  Pflugers Arch       Date:  2014-10-09       Impact factor: 3.657

8.  The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors.

Authors:  Rui Wang; Gary R Lewin
Journal:  J Physiol       Date:  2011-02-28       Impact factor: 5.182

9.  Cav1.2 and Cav1.3 L-type calcium channels independently control short- and long-term sensitization to pain.

Authors:  Houda Radwani; Maria José Lopez-Gonzalez; Daniel Cattaert; Olivier Roca-Lapirot; Eric Dobremez; Rabia Bouali-Benazzouz; Emelía Eiríksdóttir; Ülo Langel; Alexandre Favereaux; Mohammed Errami; Marc Landry; Pascal Fossat
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

Review 10.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.